GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Shanghai Haohai Biological Technology Co 688366.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

29.47

-1.77%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

5 analysts, 1 Mar 2026. The analysts' own views, not ours.

  • 2Strong buy
  • 2Buy
  • 1Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 21 Feb 2026. Not our view.

Average target 66.21

Low
65.56
Average
66.21
Median
66.21
High
68.16

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028
RevenueCN¥2.62bnCN¥2.82bnCN¥2.56bn
Revenue, highestCN¥2.62bnCN¥2.82bnCN¥2.56bn
Revenue, lowestCN¥2.62bnCN¥2.82bnCN¥2.56bn
Earnings per share1.721.912.05
Earnings per share, highest1.721.912.05
Earnings per share, lowest1.721.912.05
Analysts111

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

5 / 10

Revenue growth 14.1% a year over 10 years. Return on equity 4.6%.

Model fair value

57.48

From earnings 57.48, from revenue 53.55.

Piotroski score

4 / 9

A nine-point test of financial strength, for 31 Dec 2024.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.